TY - JOUR
AU - RECOVERY Collaborative Group
PY - 2022
DA - July
TI - Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis
JO - The Lancet
EP - 368
VL - 400
IS - 10349
DO - https://doi.org/10.1016/S0140-6736(22)01109-6
AB - We aimed to evaluate the use of baricitinib, a Janus kinase (JAK) 1–2 inhibitor, for the treatment of patients admitted to hospital with COVID-19.
PB - Elsevier
UR - https://hdl.handle.net/2164/18987
KW - Coronavirus (COVID-19)
KW - Hospital care
ER